Literature DB >> 33551977

Dynamics in Endolymphatic Hydrops & Symptoms in Meniere's Disease After Endolymphatic Duct Blockage, Preliminary Results.

Jun He1, Anquan Peng1, Junjiao Hu2, Zhiwen Zhang1, Yichao Chen1, Qin Wang1, Wei Liu1, Huang Chao1, Kai Deng2, Wenqi Jiang1.   

Abstract

Objective: The purpose of the present study was to evaluate the dynamics of endolymphatic hydrops (EH) and symptoms in a group of patients who underwent endolymphatic duct blockage (EDB) for treatment of intractable Meniere's Disease (MD), and to explore a metric for verifying the effectiveness of EDB procedure.
Methods: A total of 22 patients with intractable MD patients who underwent EDB participated in the present study. EH was visualized using locally enhanced inner ear magnetic resonance imaging (MRI) prior to and following surgery. The vestibular hydrops ratio (VHR) in the second MRI examination was compared with the pre-surgery recordings.
Results: Following EDB, 6 patients exhibited complete or partial reversal of EH, complete control of vertigo spells and reported improvement in hearing; 13 patients showed no changes in EH or hearing, but 5 of these patients exhibited complete control of vertigo attacks, and the other 8 patients exhibited improved control of vertigo attacks. The final 3 patients showed an increase in EH, but symptomatic worsening in 2 patients, and symptomatic improvement in 1 patient. There was a significant difference in the average VHR prior to and following EDB. Postoperative VHR was positively correlated with the frequency of vertigo spells in the latest 6 months of follow-up and improvement of postoperative average hearing threshold.
Conclusion: The decreased EH accompanying the reduction in vertigo attacks and hearing preservation may provide a metric for verifying the effectiveness of EDB treatment in patients with MD.
Copyright © 2021 He, Peng, Hu, Zhang, Chen, Wang, Liu, Chao, Deng and Jiang.

Entities:  

Keywords:  Ménière's disease; dynamics; endolymphatic duct blockage; endolymphatic hydrops; symptoms; treatment

Year:  2021        PMID: 33551977      PMCID: PMC7859097          DOI: 10.3389/fneur.2020.622760

Source DB:  PubMed          Journal:  Front Neurol        ISSN: 1664-2295            Impact factor:   4.003


  37 in total

1.  Change in endolymphatic hydrops 2 years after endolymphatic sac surgery evaluated by MRI.

Authors:  Kayoko Higashi-Shingai; Takao Imai; Tomoko Okumura; Atsuhiko Uno; Tadashi Kitahara; Arata Horii; Yumi Ohta; Yasuhiro Osaki; Takashi Sato; Suzuyo Okazaki; Takefumi Kamakura; Yasumitsu Takimoto; Yoshiyuki Ozono; Yoshiyuki Watanabe; Ryusuke Imai; Yukiko Hanada; Kazuya Ohata; Ryohei Oya; Hidenori Inohara
Journal:  Auris Nasus Larynx       Date:  2018-11-27       Impact factor: 1.863

2.  Effects of endolymphatic sac decompression surgery on endolymphatic hydrops.

Authors:  Munehisa Fukushima; Tadashi Kitahara; Arata Horii; Hidenori Inohara
Journal:  Acta Otolaryngol       Date:  2013-12       Impact factor: 1.494

3.  Endolymphatic duct blockage: a randomized controlled trial of a novel surgical technique for Ménière's disease treatment.

Authors:  Issam Saliba; Nathalie Gabra; Musaed Alzahrani; Djamal Berbiche
Journal:  Otolaryngol Head Neck Surg       Date:  2014-11-17       Impact factor: 3.497

Review 4.  Visualization of endolymphatic hydrops with MR imaging in patients with Ménière's disease and related pathologies: current status of its methods and clinical significance.

Authors:  Shinji Naganawa; Tsutomu Nakashima
Journal:  Jpn J Radiol       Date:  2014-02-06       Impact factor: 2.374

5.  Placebo effect in surgery for Menière's disease: nine-year follow-up.

Authors:  P Bretlau; J Thomsen; M Tos; N J Johnsen
Journal:  Am J Otol       Date:  1989-07

6.  Magnetic resonance imaging of the inner ear after both intratympanic and intravenous gadolinium injections.

Authors:  Tatsuo Iida; Masaaki Teranishi; Tadao Yoshida; Hironao Otake; Michihiko Sone; Masahiro Kato; Mariko Shimono; Masahiro Yamazaki; Shinji Naganawa; Tsutomu Nakashima
Journal:  Acta Otolaryngol       Date:  2013-01-07       Impact factor: 1.494

7.  Changes in endolymphatic hydrops after sac surgery examined by Gd-enhanced MRI.

Authors:  Atsuhiko Uno; Takao Imai; Yoshiyuki Watanabe; Hisashi Tanaka; Tadashi Kitahara; Arata Horii; Takefumi Kamakura; Yasumitsu Takimoto; Yasuhiro Osaki; Suetaka Nishiike; Hidenori Inohara
Journal:  Acta Otolaryngol       Date:  2013-06-14       Impact factor: 1.494

8.  Placebo effect in surgery for Ménière's disease. A double-blind, placebo-controlled study on endolymphatic sac shunt surgery.

Authors:  J Thomsen; P Bretlau; M Tos; N J Johnsen
Journal:  Arch Otolaryngol       Date:  1981-05

9.  Separate visualization of endolymphatic space, perilymphatic space and bone by a single pulse sequence; 3D-inversion recovery imaging utilizing real reconstruction after intratympanic Gd-DTPA administration at 3 Tesla.

Authors:  Shinji Naganawa; Hiroko Satake; Minako Kawamura; Hiroshi Fukatsu; Michihiko Sone; Tsutomu Nakashima
Journal:  Eur Radiol       Date:  2008-03-07       Impact factor: 5.315

View more
  3 in total

1.  A comparison of endolymphatic duct blockage, endolymphatic sac drainage and endolymphatic sac decompression surgery in reversing endolymphatic hydrops in Meniere's disease.

Authors:  Anquan Peng; Junjiao Hu; Qin Wang; Xueying Pan; Zhiwen Zhang; Wenqi Jiang; Yichao Chen; Chao Huang
Journal:  J Otolaryngol Head Neck Surg       Date:  2021-12-20

2.  Up-Regulated Expression of Interferon-Gamma, Interleukin-6 and Tumor Necrosis Factor-Alpha in the Endolymphatic Sac of Meniere's Disease Suggesting the Local Inflammatory Response Underlies the Mechanism of This Disease.

Authors:  Chao Huang; Qin Wang; Xueying Pan; Wei Li; Wei Liu; Wenqi Jiang; Li Huang; Anquan Peng; Zhiwen Zhang
Journal:  Front Neurol       Date:  2022-02-23       Impact factor: 4.003

3.  Correlation of clinical parameters with endolymphatic hydrops on MRI in Meniere's disease.

Authors:  Seung Cheol Han; Young Seok Kim; Yehree Kim; Sang-Yeon Lee; Jae-Jin Song; Byung Yoon Choi; Ji-Soo Kim; Yun Jung Bae; Ja-Won Koo
Journal:  Front Neurol       Date:  2022-07-25       Impact factor: 4.086

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.